Treating neurodegeneration by modifying mitochondria: potential solutions to a “complex” problem

Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis

Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914 · see citing works

Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α

Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057 · see citing works

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

Betarbet, R., Sherer, T., Mackenzie, G., Garcia-Osuna, M., Panov, A., & Greenamyre, J. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,797 · see citing works

Mitochondrial free radical generation, oxidative stress, and aging

Cadenas, E., & Davies, K. J. A. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00317-8 · Cited by 3,010 · see citing works

Premature ageing in mice expressing defective mitochondrial DNA polymerase

Trifunovic, A., Wredenberg, A., Falkenberg, M., Spelbrink, J. N., Rovio, A. T., Bruder, C. E., Bohlooly-Y, M., Gidlöf, S., Oldfors, A., Wibom, R., et al. (2004) · Nature · doi:10.1038/nature02517 · Cited by 2,734 · see citing works

A "Silent" Polymorphism in the <i>MDR</i> 1 Gene Changes Substrate Specificity

Kimchi-Sarfaty, C., Oh, J. M., Kim, I.-W., Sauna, Z. E., Calcagno, A. M., Ambudkar, S. V., & Gottesman, M. M. (2007) · Science · doi:10.1126/science.1135308 · Cited by 2,416 · see citing works

A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease

Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380 · see citing works

Mitochondrial Complex I Deficiency in Parkinson's Disease

Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283 · see citing works

Suppression of Reactive Oxygen Species and Neurodegeneration by the PGC-1 Transcriptional Coactivators

St-Pierre, J., Drori, S., Uldry, M., Silvaggi, J. M., Rhee, J., Jäger, S., Handschin, C., Zheng, K., Lin, J., Yang, W., et al. (2006) · Cell · doi:10.1016/j.cell.2006.09.024 · Cited by 2,233 · see citing works

Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging

Kujoth, G. C., Hiona, A., Pugh, T. D., Someya, S., Panzer, K., Wohlgemuth, S. E., Hofer, T., Seo, A. Y., Sullivan, R., Jobling, W. A., et al. (2005) · Science · doi:10.1126/science.1112125 · Cited by 2,165 · see citing works

The Biologic Clock: The Mitochondria?

Harman, D. (1972) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1972.tb00787.x · Cited by 1,991 · see citing works

Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment

Petersen, R. C., Thomas, R. G., Grundman, M., Bennett, D., Doody, R., Ferris, S., Galasko, D., Jin, S., Kaye, J., Levey, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050151 · Cited by 1,844 · see citing works

Thiazolidinediones

Yki-Järvinen, H. (2004) · New England Journal of Medicine · doi:10.1056/nejmra041001 · Cited by 1,830 · see citing works

The Many Faces of PPARγ

Lehrke, M., & Lazar, M. A. (2005) · Cell · doi:10.1016/j.cell.2005.11.026 · Cited by 1,452 · see citing works

Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease

Dexter, D. T., Carter, C. J., Wells, F. R., Javoy-Agid, F., Agid, Y., Lees, A. J., Jenner, P. G., & MARSDEN, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09133.x · Cited by 1,397 · see citing works

Mitochondrial abnormalities in Alzheimer's disease

Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03017.2001 · Cited by 1,367 · see citing works

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine

Nicklas, W. J., Vyas, I. L., & Heikkila, R. E. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90146-8 · Cited by 1,266 · see citing works

Mitochondrial Genetics: A Paradigm for Aging and Degenerative Diseases?

Wallace, D. C. (1992) · Science · doi:10.1126/science.1533953 · Cited by 1,256 · see citing works

Effects of Tocopherol and Deprenyl on the Progression of Disability in Early Parkinson's Disease

The Parkinson Study Group (1993) · New England Journal of Medicine · doi:10.1056/nejm199301213280305 · Cited by 1,222 · see citing works

Peroxisome proliferator-activated receptor a target genes

Mandard, S., M�ller, M., & Kersten, S. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3216-3 · Cited by 1,222 · see citing works

MITOCHONDRIAL DNA MUTATIONS AS AN IMPORTANT CONTRIBUTOR TO AGEING AND DEGENERATIVE DISEASES

Linnane, A. W., Ozawa, T., Marzuki, S., & Tanaka, M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92145-4 · Cited by 1,192 · see citing works

Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS

Nisoli, E., Tonello, C., Cardile, A., Cozzi, V., Bracale, R., Tedesco, L., Falcone, S., Valerio, A., Cantoni, O., Clementi, E., et al. (2005) · Science · doi:10.1126/science.1117728 · Cited by 1,107 · see citing works

Dietary Intake of Antioxidants and Risk of Alzheimer Disease

Engelhart, M. J. (2002) · JAMA · doi:10.1001/jama.287.24.3223 · Cited by 1,080 · see citing works

Abnormalities of the electron transport chain in idiopathic parkinson's disease

Parker, W. D., Boyson, S. J., & Parks, J. K. (1989) · Annals of Neurology · doi:10.1002/ana.410260606 · Cited by 1,061 · see citing works

Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines

Panov, A. V., Gutekunst, C.-A., Leavitt, B. R., Hayden, M. R., Burke, J. R., Strittmatter, W. J., & Greenamyre, J. T. (2002) · Nature Neuroscience · doi:10.1038/nn884 · Cited by 1,030 · see citing works

Transcriptional Repression of PGC-1α by Mutant Huntingtin Leads to Mitochondrial Dysfunction and Neurodegeneration

Cui, L., Jeong, H., Borovecki, F., Parkhurst, C. N., Tanese, N., & Krainc, D. (2006) · Cell · doi:10.1016/j.cell.2006.09.015 · Cited by 1,012 · see citing works

Effects of Coenzyme Q10 in Early Parkinson Disease: Evidence of Slowing of the Functional Decline

Shults, C. W. (2002) · Archives of Neurology · doi:10.1001/archneur.59.10.1541 · Cited by 984 · see citing works

Mitochondria take center stage in aging and neurodegeneration

Beal, M. F. (2005) · Annals of Neurology · doi:10.1002/ana.20624 · Cited by 957 · see citing works

Mitochondrial role in cell aging

Miquel, J., Economos, A. C., Fleming, J., & Johnson, J. E. (1980) · Experimental Gerontology · doi:10.1016/0531-5565(80)90010-8 · Cited by 937 · see citing works

Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age

Corral-Debrinski, M., Horton, T., Lott, M. T., Shoffner, J. M., Flint Beal, M., & Wallace, D. C. (1992) · Nature Genetics · doi:10.1038/ng1292-324 · Cited by 890 · see citing works

Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia

Browne, S. E., Bowling, A. C., Macgarvey, U., Baik, M. J., Berger, S. C., Muquit, M. M. K., Bird, E. D., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410410514 · Cited by 885 · see citing works

Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons

Kraytsberg, Y., Kudryavtseva, E., McKee, A. C., Geula, C., Kowall, N. W., & Khrapko, K. (2006) · Nature Genetics · doi:10.1038/ng1778 · Cited by 884 · see citing works

Expanding insights of mitochondrial dysfunction in Parkinson's disease

Abou-Sleiman, P. M., Muqit, M. M. K., & Wood, N. W. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1868 · Cited by 869 · see citing works

Human Catechol- <i>O</i> -Methyltransferase Haplotypes Modulate Protein Expression by Altering mRNA Secondary Structure

Nackley, A. G., Shabalina, S. A., Tchivileva, I. E., Satterfield, K., Korchynskyi, O., Makarov, S. S., Maixner, W., & Diatchenko, L. (2006) · Science · doi:10.1126/science.1131262 · Cited by 848 · see citing works

Spastic Paraplegia and OXPHOS Impairment Caused by Mutations in Paraplegin, a Nuclear-Encoded Mitochondrial Metalloprotease

Casari, G., Fusco, M. D., Ciarmatori, S., Zeviani, M., Mora, M., Fernández‐Silva, P., Michele, G. D., Filla, A., Cocozza, S., Marconi, R., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81203-9 · Cited by 826 · see citing works

PPAR and human metabolic disease

Semple, R. K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28003 · Cited by 823 · see citing works

Oxidative Alterations in Alzheimer's Disease

Markesbery, W. R., & Carney, J. M. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00215.x · Cited by 789 · see citing works

Mitochondrial defect in Huntington's disease caudate nucleus

Gu, M., Gash, M. T., Mann, V. M., Javoy‐Agid, F., Cooper, J. M., & Schapira, A. H. V. (1996) · Annals of Neurology · doi:10.1002/ana.410390317 · Cited by 758 · see citing works

Parkinson's disease: A disorder due to nigral glutathione deficiency?

Perry, T. L., Godin, D. V., & Hansen, S. (1982) · Neuroscience Letters · doi:10.1016/0304-3940(82)90390-1 · Cited by 753 · see citing works

Deficiencies in Complex I subunits of the respiratory chain in Parkinson's disease

Mizuno, Y., Ohta, S., Tanaka, M., Takamiya, S., Suzuki, K., SATO, T. A., Oya, H., Ozawa, T., & Kagawa, Y. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91141-8 · Cited by 735 · see citing works

Aging-Dependent Large Accumulation of Point Mutations in the Human mtDNA Control Region for Replication

Michikawa, Y., Mazzucchelli, F., Bresolin, N., Scarlato, G., & Attardi, G. M. (1999) · Science · doi:10.1126/science.286.5440.774 · Cited by 725 · see citing works

Genetics of Parkinson disease: paradigm shifts and future prospects

Farrer, M. J. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1831 · Cited by 709 · see citing works

Subcutaneous Rotenone Exposure Causes Highly Selective Dopaminergic Degeneration and α-Synuclein Aggregation

Sherer, T., Kim, J.-H., Betarbet, R. S., & Greenamyre, J. T. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.8072 · Cited by 707 · see citing works

Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer’s disease

Risner, M. E., Saunders, A. M., Altman, J. F. B., Ormandy, G. C., Craft, S., Foley, I. M., Zvartau-Hind, M. E., Hosford, D. A., Roses, A. D., & for the Rosiglitazone in Alzheimer's Disease Study Group (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500369 · Cited by 686 · see citing works

REGIONAL CEREBRAL OXYGEN SUPPLY AND UTILIZATION IN DEMENTIA: A CLINICAL AND PHYSIOLOGICAL STUDY WITH OXYGEN-15 AND POSITRON TOMOGRAPHY A CLINICAL AND PHYSIOLOGICAL STUDY WITH OXYGEN - 15 AND POSITRON TOMOHRAPHY

Frackowiak, R. S. J., Pozzilli, C., Legg, N. J., du Boulay, G. H., MARSHALL, J., Lenzi, G. L., & Jones, T. (1981) · Brain · doi:10.1093/brain/104.4.753 · Cited by 685 · see citing works

Regulation of mitochondrial biogenesis in skeletal muscle by CaMK

Wu, H., Kanatous, S. B., Thurmond, F. A., Gallardo, T., Isotani, E., Bassel-Duby, R., & Williams, R. S. (2002) · Science · doi:10.1126/science.1071163 · Cited by 684 · see citing works

Mitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress

Lee, H., & Wei, Y. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.09.010 · Cited by 660 · see citing works

The mitochondrial energy transduction system and the aging process

Navarro, A., & Boveris, A. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00213.2006 · Cited by 646 · see citing works

Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease

Lovell, M. A., Ehmann, W. D., Butler, S. M., & Markesbery, W. R. (1995) · Neurology · doi:10.1212/wnl.45.8.1594 · Cited by 644 · see citing works

Origin and functional consequences of the complex I defect in Parkinson's disease

Swerdlow, R. H., Parks, J. K., Miller, S. W., Davis, R. E., Tuttle, J. B., Trimmer, P. A., Sheehan, J. P., Bennett, J. P., & Parker, W. D. (1996) · Annals of Neurology · doi:10.1002/ana.410400417 · Cited by 638 · see citing works

Preserved Cognition in Patients With Early Alzheimer Disease and Amnestic Mild Cognitive Impairment During Treatment With Rosiglitazone

Watson, G. S., Cholerton, B. A., Reger, M. A., Baker, L. D., Plymate, S. R., Asthana, S., Fishel, M. A., Kulstad, J. J., Green, P. S., Cook, D. G., et al. (2005) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.13.11.950 · Cited by 607 · see citing works

Cytochrome oxidase deficiency in Alzheimer’s disease

Parker, W. D., Filley, C. M., & Parks, J. K. (1990) · Neurology · doi:10.1212/wnl.40.8.1302 · Cited by 598 · see citing works

Acute treatment with the PPARγ agonist pioglitazone and ibuprofen reduces glial inflammation and Aβ1–42 levels in APPV717I transgenic mice

Heneka, M. T., Sastre, M., Dumitrescu-Ozimek, L., Hanke, A., Dewachter, I., Kuiperi, C., O'Banion, K., Klockgether, T., Van Leuven, F., & Landreth, G. E. (2005) · Brain · doi:10.1093/brain/awh452 · Cited by 565 · see citing works

Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1α in Huntington's disease neurodegeneration

Weydt, P., Pineda, V. V., Torrence, A. E., Libby, R. T., Satterfield, T. F., Lazarowski, E. R., Gilbert, M. L., Morton, G. J., Bammler, T. K., Strand, A. D., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.10.004 · Cited by 562 · see citing works

Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication

Coskun, P. E., Beal, M. F., & Wallace, D. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403649101 · Cited by 556 · see citing works

Effectiveness of high‐dose riboflavin in migraine prophylaxis A randomized controlled trial

Schoenen, J., Jacquy, J., & Lenaerts, M. (1998) · Neurology · doi:10.1212/wnl.50.2.466 · Cited by 548 · see citing works

Alzheimer's disease

Foster, N. L., Chase, T. N., Fedio, P., Patronas, N. J., Brooks, R. A., & Chiro, G. D. (1983) · Neurology · doi:10.1212/wnl.33.8.961 · Cited by 540 · see citing works

Brain cytochrome oxidase in Alzheimer's disease

Kish, S. J., Bergeron, C., Rajput, A., Dozic, S., Mastrogiacomo, F., Chang, L., Wilson, J. M., DiStefano, L. M., & Nobrega, J. N. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09439.x · Cited by 537 · see citing works

Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice

Kieran, D., Kalmár, B., Dick, J. R. T., Riddoch‐Contreras, J., Burnstock, G., & Greensmith, L. (2004) · Nature Medicine · doi:10.1038/nm1021 · Cited by 522 · see citing works

Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release

Choo, Y. S. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh162 · Cited by 515 · cited 1× · see citing works

Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease

Marcus, D. L., Thomas, C., Rodriguez, C., Simberkoff, K., Tsai, J. S., Strafaci, J. A., & Freedman, M. L. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6750 · Cited by 513 · see citing works

Nuclear control of respiratory gene expression in mammalian cells

Scarpulla, R. C. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20743 · Cited by 489 · see citing works

Role of Mitochondria in Oxidative Stress and Aging

Lenaz, G., Bovina, C., D’Aurelio, M., Fato, R., Formiggini, G., Genova, M. L., GIULIANO, G., Pich, M. M., Paolucci, U., Castelli, G. P., et al. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb02094.x · Cited by 489 · see citing works

Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin

Koutníková, H., Campuzano, V., Foury, F., Dollé, P., Cazzalini, O., & Koenig, M. (1997) · Nature Genetics · doi:10.1038/ng0897-345 · Cited by 473 · see citing works

Regional Cerebral Metabolic Alterations in Dementia of the Alzheimer Type

Friedland, R. P., Budinger, T. F., Ganz, E., Yano, Y., Mathis, C. A., Koss, B., Ober, B. A., Huesman, R. H., & Derenzo, S. (1983) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-198308000-00003 · Cited by 468 · see citing works

Pioglitazone Induces Mitochondrial Biogenesis in Human Subcutaneous Adipose Tissue In Vivo

Bogacka, I., Xie, H., Bray, G. A., & Smith, S. R. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1392 · Cited by 467 · see citing works

A Selective Increase in Particulate Superoxide Dismutase Activity in Parkinsonian Substantia Nigra

Saggu, H. K., Cooksey, J., Dexter, D. T., Wells, F. R., Lees, A. J., Jenner, P. G., & MARSDEN, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb11759.x · Cited by 454 · see citing works

A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease

The NINDS NET-PD Investigators (2006) · Neurology · doi:10.1212/01.wnl.0000201252.57661.e1 · Cited by 453 · see citing works

Differential Expression of Oxidative Phosphorylation Genes in Patients With Alzheimer's Disease: Implications for Early Mitochondrial Dysfunction and Oxidative Damage

Mańczak, M., Park, B. S., Jung, Y., & Reddy, P. H. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:5:2:147 · Cited by 432 · see citing works

Reduced Activities of Thiamine-Dependent Enzymes in the Brains and Peripheral Tissues of Patients With Alzheimer's Disease

Gibson, G. E., Sheu, K. ‐. R., Blass, J. P., Baker, A., Carlson, K., Harding, B. N., & Perrino, P. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520320022009 · Cited by 425 · see citing works

Antioxidant Vitamin Intake and Risk of Alzheimer Disease

Luchsinger, J. A., Tang, M.-X., Shea, S., & Mayeux, R. (2003) · Archives of Neurology · doi:10.1001/archneur.60.2.203 · Cited by 414 · see citing works

Brain Peroxidase and Catalase in Parkinson Disease

Ambani, L. M., Woert, M. H. V., & Murphy, S. (1975) · Archives of Neurology · doi:10.1001/archneur.1975.00490440064010 · Cited by 404 · see citing works

Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain

Sorbi, S., Bird, E. D., & Blass, J. P. (1983) · Annals of Neurology · doi:10.1002/ana.410130116 · Cited by 395 · see citing works

Transcriptional activators and coactivators in the nuclear control of mitochondrial function in mammalian cells.

Scarpulla, R. (2002) · Gene · doi:10.1016/s0378-1119(01)00809-5 · Cited by 371 · see citing works

High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain

Lin, M. T. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.2.133 · Cited by 366 · see citing works

Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity

Smith, W. W., Jiang, H., Pei, Z., Tanaka, Y., Morita, H., Sawa, A., Dawson, V. L., Dawson, T. M., & Ross, C. A. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi396 · Cited by 365 · see citing works

Dichloroacetate causes toxic neuropathy in MELAS

Kaufmann, P., Engelstad, K., Wei, Y., Jhung, S., Sano, M. C., Shungu, D. C., Millar, W. S., Hong, X., Gooch, C. L., Mao, X., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000196641.05913.27 · Cited by 365 · see citing works

Bioenergetic and oxidative stress in neurodegenerative diseases

Bowling, A. C., & Beal, M. F. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00055-b · Cited by 364 · see citing works

Locus ceruleus lesions and eosinophilic inclusions in MPTP‐treated monkeys

Forno, L. S., Langston, J. W., DeLanney, L. E., Irwin, I., & Ricaurte, G. A. (1986) · Annals of Neurology · doi:10.1002/ana.410200403 · Cited by 351 · see citing works

Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?

Tayebi, N. (2003) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(03)00071-4 · Cited by 327 · see citing works

Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease

Reddy, P. H., McWeeney, S. K., Park, B. S., Mańczak, M., Gutala, R. V., Partovi, D., Jung, Y., Yau, V., Searles, R. P., Mori, M., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh140 · Cited by 327 · see citing works

Oxidative Damage in Huntington's Disease Pathogenesis

Browne, S. E., & Beal, M. F. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.2061 · Cited by 309 · see citing works

The development of mitochondrial medicine.

Luft, R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8731 · Cited by 302 · see citing works

A clinical trial of creatine in ALS

Shefner, J. M., Cudkowicz, M., Schoenfeld, D., Conrad, T. M., Taft, J., Chilton, M., Urbinelli, L., Qureshi, M., Zhang, H., Pestronk, A., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000142992.81995.f0 · Cited by 293 · see citing works

Analysis of European mitochondrial haplogroups with Alzheimer disease risk

van der Walt, J. M., Dementieva, Y. A., Martin, E. R., Scott, W. K., Nicodemus, K. K., Kroner, C. C., Welsh-Bohmer, K. A., Saunders, A. M., Roses, A. D., Small, G. W., et al. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.04.051 · Cited by 280 · see citing works

Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta-analysis

Etminan, M., Gill, S. S., & Samii, A. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70097-1 · Cited by 279 · see citing works

Receptor-independent actions of PPAR thiazolidinedione agonists: Is mitochondrial function the key?

Feinstein, D. L., Spagnolo, A., Akar, C., Weinberg, G., Murphy, P., Gavrilyuk, V., & Russo, C. D. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.03.033 · Cited by 275 · see citing works

A novel hypothesis of lipofuscinogenesis and cellular aging based on interactions between oxidative stress and autophagocytosis

Brunk, U. T., Jones, C. B., & Sohal, R. S. (1992) · Mutation Research/DNAging · doi:10.1016/0921-8734(92)90042-n · Cited by 274 · see citing works

Rescue of a mitochondrial deficiency causing Leber hereditary optic neuropathy

Guy, J. R., Qi, X., Pallotti, F., Schon, E. A., Manfredi, G., Carelli, V., Martinuzzi, A., Hauswirth, W. W., & Lewin, A. S. (2002) · Annals of Neurology · doi:10.1002/ana.10354 · Cited by 273 · see citing works

Parkin enhances mitochondrial biogenesis in proliferating cells

Kuroda, Y., Mitsui, T., Kunishige, M., Shono, M., Akaike, M., Azuma, H., & Matsumoto, T. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl006 · Cited by 268 · see citing works

Peroxisome Proliferator-Activated Receptors γ and α Mediate in Vivo Regulation of Uncoupling Protein (UCP-1, UCP-2, UCP-3) Gene Expression

Kelly, L. J., Vicario, P. P., Thompson, G. M., Candelore, M. R., Doebber, T. W., Ventre, J. R., Wu, M. S., Meurer, R. D., Forrest, M. J., Conner, M. W., et al. (1998) · Endocrinology · doi:10.1210/endo.139.12.6384 · Cited by 268 · see citing works

Regional Mitochondrial Respiratory Activity in Huntington's Disease Brain

Brennan, W. A., Bird, E. D., & Aprille, J. R. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb07192.x · Cited by 265 · see citing works

Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease

Cassarino, D. S., Fall, C. P., Swerdlow, R. H., Smith, T. S., Halvorsen, E. M., Miller, S. W., Parks, J. K., Parker, W. D., & Bennett, J. P. (1997) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(97)00070-7 · Cited by 265 · see citing works

Environment, Mitochondria, and Parkinson's Disease

Sherer, T., Betarbet, R., & Greenamyre, J. (2002) · The Neuroscientist · doi:10.1177/1073858402008003004 · Cited by 264 · see citing works

Oxygen toxicity protecting enzymes in Parkinson's disease

Marttila, R. J., Lorentz, H., & Rinne, U. K. (1988) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(88)90108-6 · Cited by 249 · see citing works

Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids

Taylor, R. W., Chinnery, P. F., Turnbull, D. M., & Lightowlers, R. N. (1997) · Nature Genetics · doi:10.1038/ng0297-212 · Cited by 249 · cited 1× · see citing works

MITOCHONDRIAL FUNCTION IN PARKINSON'S DISEASE

Bindoff, L. A., Birch‐Machin, M. A., Cartlidge, N. E. F., Parker, W. D., & Turnbull, D. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90291-2 · Cited by 245 · see citing works

The mitochondrial tRNA(Leu(UUR)) mutation in mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS): genetic, biochemical, and morphological correlations in skeletal muscle.

Moraes, C. T., Ricci, E., Bonilla, E., DiMauro, S., & Schon, E. A. (1992) · PubMed · Cited by 244 · see citing works

Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders

Tarnopolsky, M. A., & Beal, M. F. (2001) · Annals of Neurology · doi:10.1002/ana.1028 · Cited by 244 · see citing works

Intakes of vitamins E and C, carotenoids, vitamin supplements, and PD risk

Zhang, S., Hernán, M. Á., Chen, H., Spiegelman, D. L., Willett, W. C., & Ascherio, A. (2002) · Neurology · doi:10.1212/01.wnl.0000028688.75881.12 · Cited by 240 · see citing works

Midlife Dietary Intake of Antioxidants and Risk of Late-Life Incident Dementia: The Honolulu-Asia Aging Study

Laurin, D. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh124 · Cited by 231 · see citing works

Evidence for a defect in NADH

Parker, W. D., Boyson, S. J., LUDER, A. S., & Parks, J. K. (1990) · Neurology · doi:10.1212/wnl.40.8.1231 · Cited by 230 · see citing works

Antioxidant Treatment of Patients With Friedreich Ataxia

Hart, P. E., Lodi, R., Rajagopalan, B., Bradley, J. L., Crilley, J. G., Turner, C., Blamire, A. M., Manners, D. N., Styles, P., Schapira, A. H. V., et al. (2005) · Archives of Neurology · doi:10.1001/archneur.62.4.621 · Cited by 224 · see citing works

Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease

Shults, C. W., Flint Beal, M., Song, D., & Fontaine, D. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.05.003 · Cited by 223 · see citing works

Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease.

Chandrasekaran, K., Giordano, T., Brady, D., Stoll, J., Martin, L. J., & Rapoport, S. (1994) · Brain Research. Molecular Brain Research · doi:10.1016/0169-328x(94)90147-3 · Cited by 221 · see citing works

Abnormal brain and muscle energy metabolism shown by 31 P magnetic resonance spectroscopy in patients affected by migraine with aura

Barbiroli, B., Montagna, P., Cortelli, P., Funicello, R., Iotti, S., Monari, L., Pierangeli, G., Zaniol, P., & Lugaresi, E. (1992) · Neurology · doi:10.1212/wnl.42.6.1209 · Cited by 217 · see citing works

Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients

Bourdel‐Marchasson, I. (2001) · Age and Ageing · doi:10.1093/ageing/30.3.235 · Cited by 215 · see citing works

Mitochondrial Aging: Open Questionsa

Beckman, K. B., & Ames, B. N. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09897.x · Cited by 211 · see citing works

SNPs, Silent But Not Invisible

Komar, A. A. (2006) · Science · doi:10.1126/science.1138239 · Cited by 209 · see citing works

Clonally expanded mtDNA point mutations are abundant in individual cells of human tissues

Nekhaeva, E., Bodyak, N. D., Kraytsberg, Y., McGrath, S., van Orsouw, N. J., Pluzhnikov, A., Wei, J. Y., Vijg, J., & Khrapko, K. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072670199 · Cited by 205 · see citing works

Creatine supplementation in Parkinson disease: A placebo-controlled randomized pilot trial

Bender, A., Koch, W., Elstner, M., Schombacher, Y., Bender, J., Moeschl, M., Gekeler, F., Müller‐Myhsok, B., Gasser, T., Tatsch, K., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000238518.34389.12 · Cited by 205 · see citing works

Time‐course of mitochondrial gene expressions in mice brains: implications for mitochondrial dysfunction, oxidative damage, and cytochrome c in aging

Mańczak, M., Jung, Y., Park, B. S., Partovi, D., & Reddy, P. H. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02884.x · Cited by 192 · see citing works

Mitochondrial function in brain tissue in primary degenerative dementia

Sims, N. R., Finegan, J. M., Blass, J. P., Bowen, D. M., & Neary, D. (1987) · Brain Research · doi:10.1016/0006-8993(87)91553-8 · Cited by 182 · see citing works

Complex I Defect in muscle from patients with Huntington's disease

Arenas, J., Campos, Y., Ribacoba, R., Martín, M. A., Rubio‐Terres, C., Ablanedo, P., & Cabello, A. (1998) · Annals of Neurology · doi:10.1002/ana.410430321 · Cited by 174 · see citing works

Insulin Resistance Syndrome and Alzheimer Disease: Pathophysiologic Mechanisms and Therapeutic Implications

Craft, S. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000213866.86934.7e · Cited by 167 · see citing works

Peroxisome Proliferator-activated Receptor γ Thiazolidinedione Agonists Increase Glucose Metabolism in Astrocytes

Russo, C. D., Gavrilyuk, V., Weinberg, G. L., Almeida, Á., Bolaños, J. P., Palmer, J. W., Pelligrino, D. A., Galea, E., & Feinstein, D. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208132200 · Cited by 164 · see citing works

Creatine supplementation in Huntington’s disease

Verbessem, P., Lemiere, J., Eijnde, B. O., Swinnen, S. P., Vanhees, L., Leemputte, M. V., Hespel, P., & Dom, R. (2003) · Neurology · doi:10.1212/01.wnl.0000090629.40891.4b · Cited by 163 · see citing works

Mitochondrial Oxidative Stress: Physiologic Consequences and Potential for a Role in Aging

MELOV, S. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06649.x · Cited by 161 · see citing works

Mitochondrial encephalomyopathy (MELAS): Pathological study and successful therapy with coenzyme Q10 and idebenone

Ihara, Y., Namba, R., Kuroda, S., SATO, T. A., & Shirabe, T. (1989) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(89)90112-3 · Cited by 161 · see citing works

Idebenone treatment fails to slow cognitive decline in Alzheimer’s disease

Thal, L. J., Grundman, M., Berg, J., Ernstrom, K., Margolin, R., Pfeiffer, E., Weiner, M. F., Zamrini, E., & Thomas, R. G. (2003) · Neurology · doi:10.1212/01.wnl.0000096376.03678.c1 · Cited by 156 · see citing works

Protection Against Ischemic Brain Injury by Inhibition of Mitochondrial Oxidative Stress

Fiskum, G. M., Rosenthal, R. E., Vereczki, V., Martin, E., Hoffman, G. E., Chinopoulos, C., & Kowaltowski, A. J. (2004) · Journal of Bioenergetics and Biomembranes · doi:10.1023/b:jobb.0000041766.71376.81 · Cited by 153 · see citing works

Neuronal protection by sirtuins in Alzheimer's disease

Anekonda, T. S., & Reddy, P. H. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03492.x · Cited by 150 · see citing works

Reduced steady-state levels of mitochondrial RNA and increased mitochondrial DNA amount in human brain with aging

Barrientos, A., Casademont, J., Cardellach, F., Estivill, X., Urbano-Marquez, A., & Nunes, V. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00278-7 · Cited by 149 · see citing works

Neurochemical enzyme changes in Alzheimer's and Pick's disease

Meier‐Ruge, W., Iwangoff, P., & Reichlmeier, K. (1984) · Archives of Gerontology and Geriatrics · doi:10.1016/0167-4943(84)90007-4 · Cited by 147 · see citing works

Cytochrome C Oxidase in Alzheimer's Disease Brain: Purification and Characterization

Parker, W. D., & Parks, J. K. (1995) · Neurology · doi:10.1212/wnl.45.3.482 · Cited by 142 · see citing works

High frequency of mitochondrial complex I mutations in Parkinson’s disease and aging

Smigrodzki, R. M., Parks, J. K., & Parker, W. D. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.02.020 · Cited by 138 · see citing works

Localization of the Wilson’s disease protein product to mitochondria

Lutsenko, S., & Cooper, M. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6004 · Cited by 136 · see citing works

Thiazolidinedione exposure increases the expression of uncoupling protein 1 in cultured human preadipocytes.

Digby, J. E., Montague, C. T., Sewter, C. P., Sanders, L., Wilkison, W. O., O'Rahilly, S., & Prins, J. B. (1998) · Diabetes · doi:10.2337/diab.47.1.138 · Cited by 134 · cited 1× · see citing works

Mitochondrial Transcription Factor A in the Maintenance of Mitochondrial DNA

Kang, D., & Hamasaki, N. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1338.010 · Cited by 132 · see citing works

Peripheral antioxidant enzyme activities and selenium in elderly subjects and in dementia of Alzheimer's type—Place of the extracellular glutathione peroxidase

Ceballos-Picot, I., Merad-Boudia, M., Nicole, A., Thévenin, M., Hellier, G., Legrain, S., & Berr, C. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)02058-6 · Cited by 130 · see citing works

ENZYME HISTOCHEMICAL STUDIES OF SENILE PLAQUES

Friede, R. L. (1965) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-196507000-00008 · Cited by 128 · see citing works

Mitochondria in cybrids containing mtDNA from persons with mitochondriopathies

Swerdlow, R. H. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21167 · Cited by 128 · see citing works

Phylogenetic analysis of the mitochondrial genome indicates significant differences between patients with Alzheimer disease and controls in a French-Canadian founder population.

Chagnon, P., Gee, M., Filion, M., Robitaille, Y., Belouchi, M., & Gauvreau, D. (1999) · American journal of medical genetics · doi:10.1002/(sici)1096-8628(19990702)85:1 · Cited by 128 · see citing works

Mitochondria in Alzheimer's disease

Swerdlow, R. H., & Kish, S. J. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)53013-0 · Cited by 126 · see citing works

Metabolic Processes in Alzheimer's Disease: Adenine Nucleotide Content and Production of 14CO2 from [U‐14C]Glucose In Vitro in Human Neocortex

Sims, N. R., Bowen, D. M., Neary, D., & DAVISON, A. N. (1983) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1983.tb00829.x · Cited by 126 · see citing works

Altered metabolic properties of cultured skin fibroblasts in Alzheimer's disease

Sims, N. R., Finegan, J. M., & Blass, J. P. (1987) · Annals of Neurology · doi:10.1002/ana.410210507 · Cited by 123 · see citing works

PGC-1α

Houten, S. M., & Auwerx, J. H. (2004) · Cell · doi:10.1016/j.cell.2004.09.016 · Cited by 120 · see citing works

Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson’s disease

Simon, D. K., Lin, M. T., Zheng, L., Liu, G.-J., Ahn, C. H., Kim, L. M., Mauck, W. M., Twu, F., Beal, M. F., & Johns, D. R. (2004) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00037-x · Cited by 118 · see citing works

The Thiazolidinedione Pioglitazone Alters Mitochondrial Function in Human Neuron-Like Cells

Ghosh, S., Patel, N., Rahn, D. A., McAllister, J., Sadeghi, S., Horwitz, G., Berry, D., Wang, K. X., & Swerdlow, R. H. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.033845 · Cited by 116 · see citing works

Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease)

Roses, A. D., Saunders, A. M., Huang, Y., Strum, J. C., Weisgraber, K. H., & Mahley, R. W. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500397 · Cited by 109 · see citing works

Assessment of coenzyme q10 tolerability in huntington's disease

Feigin, A., Kieburtz, K. D., Como, P. G., Hickey, C., Abwender, D. A., Zimmerman, C., Steinberg, K., & Shoulson, I. (1996) · Movement Disorders · doi:10.1002/mds.870110317 · Cited by 108 · see citing works

Mitochondrial ND5 mutations in idiopathic Parkinson’s disease

Parker, W. D., & Parks, J. K. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.093 · Cited by 108 · see citing works

Coenzyme Q10:A Review of Its Promise as a Neuroprotectant

Young, A. J., Johnson, S., Steffens, D. C., & Doraiswamy, P. M. (2007) · CNS Spectrums · doi:10.1017/s1092852900020538 · Cited by 97 · see citing works

The Mitochondrial Myopathy Encephalopathy, Lactic Acidosis with??Stroke-Like Episodes (MELAS) Syndrome

Scaglia, F., & Northrop, J. L. (2006) · CNS Drugs · doi:10.2165/00023210-200620060-00002 · Cited by 95 · see citing works

Mitochondrial DNA as a Cancer Biomarker

Jakupciak, J. P., Wang, W., Markowitz, M. E., Ally, D. S., Coble, M. D., Srivastava, S., Maitra, A., Barker, P. E., Sidransky, D., & O’Connell, C. D. (2005) · Journal of Molecular Diagnostics · doi:10.1016/s1525-1578(10)60553-3 · Cited by 93 · see citing works

Aging and mitochondria

Gadaleta, M. N., Cormio, A., Pesce, V., Lezza, A. M. S., & Cantatore, P. (1998) · Biochimie · doi:10.1016/s0300-9084(00)88881-1 · Cited by 86 · see citing works

Effectiveness of high-dose riboflavin in migraine prophylaxis

Yee, A. J., & Schoenen, J. E. (1999) · Neurology · doi:10.1212/wnl.52.2.431-a · Cited by 85 · see citing works

Mitochondrial abnormalities in cybrid cell models of sporadic Alzheimer's disease worsen with passage in culture

Trimmer, P. A., Keeney, P. M., Borland, M. K., Simon, F. A., Almeida, J., Swerdlow, R. H., Parks, J. K., Parker, W. D., & Bennett, J. P. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.09.011 · Cited by 84 · see citing works

Hydrogen peroxide overproduction in megamitochondria of troglitazone-treated human hepatocytes

Shishido, S., Koga, H., Harada, M., Kumemura, H., Hanada, S., Taniguchi, E., Kumashiro, R., Ohira, H., Satô, Y., Namba, M., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50014 · Cited by 83 · see citing works

Somatic mitochondrial DNA mutations in single neurons and glia

Cantuti‐Castelvetri, I., Lin, M. T. S., Zheng, K., Keller-McGandy, C. E., Betensky, R. A., Johns, D. R., Beal, M. F., Standaert, D. G., & Simon, D. K. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.11.008 · Cited by 81 · see citing works

Oxidative metabolism in cultured fibroblasts derived from sporadic Alzheimer's disease (AD) patients

Curti, D., Rognoni, F., Gasparini, L., Cattaneo, A., Paolillo, M., Racchi, M., Zani, L., Bianchetti, A., Trabucchi, M., Bergamaschi, S., et al. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00741-6 · Cited by 80 · see citing works

Inhibition by R(+) or S(–) pramipexole of caspase activation and cell death induced by methylpyridinium ion or beta amyloid peptide in SH‐SY5Y neuroblastoma

Abramova, N. N., Cassarino, D. S., Khan, S. M., Painter, T. W., & Bennett, J. P. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10127 · Cited by 74 · see citing works

18F-2-deoxy-2-fluoro-D-glucose as a tracer in the positron emission tomographic study of senile dementia

Farkas, T., Ferris, S. H., Wolf, A. P., et al. (1982) · American Journal of Psychiatry · doi:10.1176/ajp.139.3.352 · Cited by 74 · see citing works

Leigh syndrome caused by mitochondrial DNA G13513A mutation: frequency and clinical features in Japan

Sudo, A., Honzawa, S., Nonaka, I., & Goto, Y. (2004) · Journal of Human Genetics · doi:10.1007/s10038-003-0116-1 · Cited by 67 · see citing works

Mitochondrial Microheteroplasmy and a Theory of Aging and Age-Related Disease

Smigrodzki, R. M., & Khan, S. M. (2005) · Rejuvenation Research · doi:10.1089/rej.2005.8.172 · Cited by 62 · see citing works

Disorders of Movement in Leigh Syndrome

Macaya, A., Munell, F., Burke, R. E., et al. (1993) · Neuropediatrics · doi:10.1055/s-2008-1071515 · Cited by 60 · see citing works

Human aging brain disorders: Role of antioxidant enzymes

Torre, M. R. D. L., Casado, Á., López-Fernández, M. E., Carrascosa, D., Casado, M. C., Venarucci, D., & Venarucci, V. (1996) · Neurochemical Research · doi:10.1007/bf02532336 · Cited by 58 · see citing works

Brain glutathione peroxidase in neurodegenerative disorders

Kish, S. J., Morito, C. L. H., & Hornykiewicz, O. (1986) · Neurochemical Pathology · doi:10.1007/bf02834296 · Cited by 58 · see citing works

Peroxisome Proliferator-Activated Receptors and Mediate in Vivo Regulation of Uncoupling Protein (UCP-1, UCP-2, UCP-3) Gene Expression

Kelly, L. J. (1998) · Endocrinology · doi:10.1210/en.139.12.4920 · Cited by 58 · see citing works

PPARγ agonists as new therapeutic agents for the treatment of Alzheimer's disease

Landreth, G. E. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.04.006 · Cited by 55 · see citing works

Effects of dichloroaeetate in three patients with MELAS

Saitoh, S., Momoi, M. Y., Yamagata, T., et al. (1998) · Neurology · doi:10.1212/wnl.50.2.531 · Cited by 55 · see citing works

Mutations in mitochondrial‐encoded cytochrome c oxidase subunits I, II, and III genes detected in Alzheimer's disease using single‐strand conformation polymorphism

Hamblet, N. S., Ragland, B. D., Ali, M. A., Conyers, B., & Castora, F. J. (2005) · Electrophoresis · doi:10.1002/elps.200500420 · Cited by 53 · see citing works

Serum antioxidant enzyme activity in Parkinson's disease

Kalra, J., Rajput, A. H., Mantha, S. V., et al. (1992) · Molecular and Cellular Biochemistry · doi:10.1007/bf02454194 · Cited by 53 · see citing works

Mutation and intracellular clonal expansion of mitochondrial genomes: two synergistic components of the aging process?

Kraytsberg, Y., Nekhaeva, E., Bodyak, N. B., & Khrapko, K. (2003) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(02)00169-0 · Cited by 52 · see citing works

Mitochondria‐derived oxidative stress induces a heat shock protein response

Barrett, M. J., Alones, V., Wang, K. X., Phan, L., & Swerdlow, R. H. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20249 · Cited by 51 · see citing works

Development of Mitochondrial Gene Replacement Therapy

Khan, S. M., & Bennett, J. P. (2004) · Journal of Bioenergetics and Biomembranes · doi:10.1023/b:jobb.0000041773.20072.9e · Cited by 49 · see citing works

Mitochondrial DNA mutations activate programmed cell survival in the mouse heart

Zhang, D., Mott, J. L., Chang, S.-W., Stevens, M., Mikolajczak, P., & Zassenhaus, H. P. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00670.2004 · Cited by 49 · see citing works

How is Mitochondrial Biogenesis Affected in Mitochondrial Disease?

Chabi, B., Adhihetty, P. J., Ljubicic, V., & Hood, D. A. (2005) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000177426.68149.83 · Cited by 44 · see citing works

Role of mitochondria in amyotrophic lateral sclerosis

Swerdlow, R. H., Parks, J. K., Pattee, G. L., & Parker, W. D. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820050515179 · Cited by 41 · see citing works

Correlation of the clinical severity of Alzheimer's disease with an aberration in mitochondrial DNA (mtDNA)

Brown, A. M., Sheu, R. K.-F., Mohs, R., Haroutunian, V., & Blass, J. P. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:16:1:41 · Cited by 40 · see citing works

In VivoEffects of Pioglitazone on Uncoupling Protein-2 and -3 mRNA Levels in Skeletal Muscle of Hyperglycemic KK Mice

Shimokawa, T., Kato, M., Watanabe, Y., Hirayama, R., Kurosaki, E., Shikama, H., & Hashimoto, S. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9479 · Cited by 38 · see citing works

Current opinions in headache pathogenesis: introduction and synthesis

Welch, K. M. A. (1998) · Current Opinion in Neurology · doi:10.1097/00019052-199806000-00001 · Cited by 35 · see citing works

LRRK2

Foroud, T. (2005) · Neurology · doi:10.1212/01.wnl.0000179342.58181.c9 · Cited by 34 · see citing works

Huntington's Disease — Making Connections

Greenamyre, J. T. (2007) · New England Journal of Medicine · doi:10.1056/nejmcibr067022 · Cited by 33 · see citing works

Superoxide Dismutase Expression in Parkinson's Disease

Poirier, J., Dea, D., Baccichet, A., & THIFFAUL, C. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb21796.x · Cited by 31 · see citing works

Transcription meets metabolism in neurodegeneration

Ross, C. A., & Thompson, L. M. (2006) · Nature Medicine · doi:10.1038/nm1106-1239 · Cited by 30 · see citing works

Tissue-Specific Effect of Age and Caloric Restriction Diet on Mitochondrial DNA Content

Cassano, P., Sciancalepore, A. G., Lezza, A. M. S., Leeuwenburgh, C., Cantatore, P., & Gadaleta, M. N. (2006) · Rejuvenation Research · doi:10.1089/rej.2006.9.211 · Cited by 29 · see citing works

Is NADH Effective in the Treatment of Parkinson??s Disease?

Swerdlow, R. H. (1998) · Drugs & Aging · doi:10.2165/00002512-199813040-00002 · Cited by 24 · see citing works

Complex I polymorphisms, bigenomic heterogeneity, and family history in Virginians with Parkinson's disease

Swerdlow, R. H., Weaver, B., Grawey, A. E., Wenger, C., Freed, E., & Worrall, B. B. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.05.053 · Cited by 23 · see citing works

Thiazolidinedione exposure increases the expression of uncoupling protein 1 in cultured human preadipocytes

Digby, J., Montague, C. T., Sewter, C. P., et al. (1998) · Diabetes · doi:10.2337/diabetes.47.1.138 · Cited by 23 · see citing works

Where and When Do Somatic mtDNA Mutations Occur?

Khrapko, K., Ebralidse, K. K., & Kraytsberg, Y. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1297.040 · Cited by 15 · see citing works

Endogenous sodium-potassium ATPase inhibition related biochemical cascade in trisomy 21 and Huntington's disease: neural regulation of genomic function.

Kumar, A. R., & Kurup, P. A. (2002) · PubMed · Cited by 12 · see citing works

Cross talk between mitochondria and NADPH oxidases

Dikalov, S. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.06.033 · Cited by 783 · see citing works

The Alzheimer’s disease mitochondrial cascade hypothesis: progress and perspectives

Swerdlow, R. H., Burns, J. M., & Khan, S. M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.09.010 · Cited by 786 · see citing works

The Alzheimer’s Disease Mitochondrial Cascade Hypothesis

Swerdlow, R. H., Burns, J. M., & Khan, S. M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100339 · Cited by 562 · see citing works

Mammalian Mitochondrial Complex I: Biogenesis, Regulation, and Reactive Oxygen Species Generation

Koopman, W. J. H., Nijtmans, L. G. J., Dieteren, C. E. J., Roestenberg, P., Valsecchi, F., Smeitink, J. A. M., & Willems, P. H. G. M. (2010) · Antioxidants &amp; Redox Signaling · doi:10.1089/ars.2009.2743 · Cited by 411 · see citing works

In vitro and in vivo antioxidant and anti-inflammatory capacities of an antioxidant-rich fruit and berry juice blend. Results of a pilot and randomized, double-blinded, placebo-controlled, crossover study

Jensen, G. S., Wu, X., Patterson, K. M., Barnes, J., Carter, S. G., Scherwitz, L., Beaman, R., Endres, J. R., & Schauss, A. G. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf8016157 · Cited by 245 · see citing works

Mitochondrial Medicine for Aging and Neurodegenerative Diseases

Reddy, P. H. (2008) · NeuroMolecular Medicine · doi:10.1007/s12017-008-8044-z · Cited by 230 · see citing works

The Alzheimer's disease mitochondrial cascade hypothesis: an update

Swerdlow, R. H., & Khan, S. M. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.01.011 · Cited by 206 · see citing works

The Role of Mitochondria-Derived Reactive Oxygen Species in Hyperthermia-Induced Platelet Apoptosis

Wang, Z., Cai, F., Chen, X., Luo, M., Hu, L., & Lu, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075044 · Cited by 155 · see citing works

Maternal transmission of Alzheimer's disease: prodromal metabolic phenotype and the search for genes

Mosconi, L., Berti, V., Swerdlow, R. H., Pupi, A., Duara, R., & de Leon, M. (2010) · Human Genomics · doi:10.1186/1479-7364-4-3-170 · Cited by 85 · see citing works

Mitochondrial peptidase IMMP2L mutation causes early onset of age‐associated disorders and impairs adult stem cell self‐renewal

George, S. K., Jiao, Y., Bishop, C. E., & Lu, B. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00686.x · Cited by 66 · see citing works

Mitochondrial medicine and the neurodegenerative mitochondriopathies

Swerdlow, R. H. (2009) · Pharmaceuticals · doi:10.3390/ph2030150 · Cited by 43 · see citing works

Role and treatment of mitochondrial DNA-related mitochondrial dysfunction in sporadic neurodegenerative diseases

H. Swerdlow, R. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798072535 · Cited by 35 · see citing works

Sex-related differences in oxidative stress and neurodegeneration

Tenkorang, M. A. A., Snyder, B., & Cunningham, R. L. (2017) · Steroids · doi:10.1016/j.steroids.2017.12.010 · Cited by 116 · see citing works

Transducing oxidative stress to death signals in neurons

Cao, X., & Fang, Y. (2015) · The Journal of Cell Biology · doi:10.1083/jcb.201510105 · Cited by 17 · see citing works

Protein aggregation, metals and oxidative stress in neurodegenerative diseases

Tabner, B. J., El-Agnaf, O. M. A., German, M. J., Fullwood, N. J., & Allsop, D. (2005) · Biochemical Society Transactions · doi:10.1042/bst20051082 · Cited by 118 · see citing works

Effects of Polyphenols in Aging and Neurodegeneration Associated with Oxidative Stress

Rivas, F., Poblete-Aro, C., Pando, M. E., Allel, M. J., Fernández, V. S., Soto, A., Nova-Baeza, P., & García‐Díaz, D. F. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666211101100632 · Cited by 36 · see citing works

Early Aβ accumulation in the mitochondria produces oxidative stress and induces neurodegeneration in APdE9 mice

Manabe, T., Yokokawa, K., Saito, T., et al. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.08.1912